1. Home
  2. RVLV vs GALT Comparison

RVLV vs GALT Comparison

Compare RVLV & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

N/A

Current Price

$21.17

Market Cap

1.5B

ML Signal

N/A

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$3.76

Market Cap

297.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVLV
GALT
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
297.0M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
RVLV
GALT
Price
$21.17
$3.76
Analyst Decision
Buy
Analyst Count
15
0
Target Price
★ $30.85
N/A
AVG Volume (30 Days)
★ 716.8K
248.5K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
24.64
★ 36.84
EPS
★ 0.46
N/A
Revenue
★ $1,225,682,000.00
N/A
Revenue This Year
$13.31
N/A
Revenue Next Year
$9.03
N/A
P/E Ratio
$46.52
★ N/A
Revenue Growth
★ 8.48
N/A
52 Week Low
$17.35
$2.03
52 Week High
$31.68
$7.13

Technical Indicators

Market Signals
Indicator
RVLV
GALT
Relative Strength Index (RSI) 46.02 54.69
Support Level $19.25 $3.56
Resistance Level $22.11 $4.30
Average True Range (ATR) 0.72 0.19
MACD 0.17 -0.01
Stochastic Oscillator 49.18 71.97

Price Performance

Historical Comparison
RVLV
GALT

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: